Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Pregnancy outcomes following maternal venlafaxine use: A prospective observational comparative cohort study.

Richardson JL, Martin F, Dunstan H, Greenall A, Stephens S, Yates LM, Thomas SHL.

Reprod Toxicol. 2019 Mar;84:108-113. doi: 10.1016/j.reprotox.2019.01.003. Epub 2019 Jan 11.

PMID:
30639403
2.

Pregnancy outcome following maternal exposure to mirtazapine: a multicenter, prospective study.

Winterfeld U, Klinger G, Panchaud A, Stephens S, Arnon J, Malm H, Te Winkel B, Clementi M, Pistelli A, Maňáková E, Eleftheriou G, Merlob P, Kaplan YC, Buclin T, Rothuizen LE.

J Clin Psychopharmacol. 2015 Jun;35(3):250-9. doi: 10.1097/JCP.0000000000000309.

PMID:
25830592
3.

In utero exposure to venlafaxine, a serotonin-norepinephrine reuptake inhibitor, increases cardiac anomalies and alters placental and heart serotonin signaling in the rat.

Laurent L, Huang C, Ernest SR, Berard A, Vaillancourt C, Hales BF.

Birth Defects Res A Clin Mol Teratol. 2016 Dec;106(12):1044-1055. doi: 10.1002/bdra.23537. Epub 2016 Jul 7.

PMID:
27384265
4.

First-Trimester Pregnancy Exposure to Venlafaxine or Duloxetine and Risk of Major Congenital Malformations: A Systematic Review.

Lassen D, Ennis ZN, Damkier P.

Basic Clin Pharmacol Toxicol. 2016 Jan;118(1):32-6. doi: 10.1111/bcpt.12497. Epub 2015 Nov 3. Review.

5.

Pregnancy outcome following gestational exposure to venlafaxine: a multicenter prospective controlled study.

Einarson A, Fatoye B, Sarkar M, Lavigne SV, Brochu J, Chambers C, Mastroiacovo P, Addis A, Matsui D, Schuler L, Einarson TR, Koren G.

Am J Psychiatry. 2001 Oct;158(10):1728-30.

PMID:
11579012
6.

Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression.

Nulman I, Koren G, Rovet J, Barrera M, Pulver A, Streiner D, Feldman B.

Am J Psychiatry. 2012 Nov;169(11):1165-74. doi: 10.1176/appi.ajp.2012.11111721.

PMID:
23128923
7.

Exposure to mirtazapine during pregnancy: a prospective, comparative study of birth outcomes.

Djulus J, Koren G, Einarson TR, Wilton L, Shakir S, Diav-Citrin O, Kennedy D, Voyer Lavigne S, De Santis M, Einarson A.

J Clin Psychiatry. 2006 Aug;67(8):1280-4.

PMID:
16965209
8.

Selective serotonin reuptake inhibitor (SSRI) use during pregnancy and risk of preterm birth: a systematic review and meta-analysis.

Eke AC, Saccone G, Berghella V.

BJOG. 2016 Nov;123(12):1900-1907. doi: 10.1111/1471-0528.14144. Epub 2016 May 30. Review.

9.
10.

Risks and safety of pandemic H1N1 influenza vaccine in pregnancy: birth defects, spontaneous abortion, preterm delivery, and small for gestational age infants.

Chambers CD, Johnson D, Xu R, Luo Y, Louik C, Mitchell AA, Schatz M, Jones KL; OTIS Collaborative Research Group.

Vaccine. 2013 Oct 17;31(44):5026-32. doi: 10.1016/j.vaccine.2013.08.097. Epub 2013 Sep 7.

PMID:
24016809
11.

Selective serotonin reuptake inhibitors and venlafaxine in early pregnancy and risk of birth defects: population based cohort study and sibling design.

Furu K, Kieler H, Haglund B, Engeland A, Selmer R, Stephansson O, Valdimarsdottir UA, Zoega H, Artama M, Gissler M, Malm H, Nørgaard M.

BMJ. 2015 Apr 17;350:h1798. doi: 10.1136/bmj.h1798. Erratum in: BMJ. 2015;350:h2235.

12.

Prenatal antidepressant exposure and risk of spontaneous abortion - a population-based study.

Kjaersgaard MI, Parner ET, Vestergaard M, Sørensen MJ, Olsen J, Christensen J, Bech BH, Pedersen LH.

PLoS One. 2013 Aug 28;8(8):e72095. doi: 10.1371/journal.pone.0072095. eCollection 2013.

13.

Use of antidepressants during pregnancy and the risk of spontaneous abortion.

Nakhai-Pour HR, Broy P, Bérard A.

CMAJ. 2010 Jul 13;182(10):1031-7. doi: 10.1503/cmaj.091208. Epub 2010 May 31.

14.

Clinical drug-drug interactions: focus on venlafaxine.

Magalhães P, Alves G, LLerena A, Falcão A.

Drug Metab Pers Ther. 2015 Mar;30(1):3-17. doi: 10.1515/dmdi-2014-0011. Review.

PMID:
24964257
15.

Safety of the 2010-11, 2011-12, 2012-13, and 2013-14 seasonal influenza vaccines in pregnancy: Birth defects, spontaneous abortion, preterm delivery, and small for gestational age infants, a study from the cohort arm of VAMPSS.

Chambers CD, Johnson DL, Xu R, Luo YJ, Louik C, Mitchell AA, Schatz M, Jones KL; OTIS Collaborative Research Group.

Vaccine. 2016 Aug 17;34(37):4443-9. doi: 10.1016/j.vaccine.2016.06.054. Epub 2016 Jul 20.

PMID:
27449682
16.

Individual-based versus aggregate meta-analysis in multi-database studies of pregnancy outcomes: the Nordic example of selective serotonin reuptake inhibitors and venlafaxine in pregnancy.

Selmer R, Haglund B, Furu K, Andersen M, Nørgaard M, Zoëga H, Kieler H.

Pharmacoepidemiol Drug Saf. 2016 Oct;25(10):1160-1169. doi: 10.1002/pds.4033. Epub 2016 May 19.

PMID:
27193296
17.

Effects of in-utero exposure to selective serotonin reuptake inhibitors and venlafaxine on term and preterm infants.

Hogue AN, Temple-Cooper ME, Lagzdins M, Worley S, Scwersenski J, Floyd R, Saker F.

J Neonatal Perinatal Med. 2017;10(4):371-380. doi: 10.3233/NPM-16133.

PMID:
29286926
18.

Antidepressant drug exposure during pregnancy. CZTIS small prospective study.

Manakova E, Hubickova L.

Neuro Endocrinol Lett. 2011;32 Suppl 1:53-6.

PMID:
22167208
19.

Associations of Maternal Antidepressant Use During the First Trimester of Pregnancy With Preterm Birth, Small for Gestational Age, Autism Spectrum Disorder, and Attention-Deficit/Hyperactivity Disorder in Offspring.

Sujan AC, Rickert ME, Öberg AS, Quinn PD, Hernández-Díaz S, Almqvist C, Lichtenstein P, Larsson H, D'Onofrio BM.

JAMA. 2017 Apr 18;317(15):1553-1562. doi: 10.1001/jama.2017.3413.

20.

Pregnancy outcome following maternal exposure to statins: a multicentre prospective study.

Winterfeld U, Allignol A, Panchaud A, Rothuizen LE, Merlob P, Cuppers-Maarschalkerweerd B, Vial T, Stephens S, Clementi M, De Santis M, Pistelli A, Berlin M, Eleftheriou G, Maňáková E, Buclin T.

BJOG. 2013 Mar;120(4):463-71. doi: 10.1111/1471-0528.12066. Epub 2012 Nov 30.

Supplemental Content

Support Center